pentobarbital will reduce the extent or impact of buprenorphine, extensive-acting injection by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Intently. Individuals who transfer to buprenorphine extended-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers must be monitored to